Want to see SSII full AI Analyst Report?
Top Page
SS Innovations International
(NASDAQ:SSII)
Select Model
Select Model
Rating:44Neutral
Price Target:
$2.00
▼(-47.78% Downside)
Action:Reiterated
Date:10/26/26
The score is held down primarily by continued losses and persistent negative operating/free cash flow despite improving revenue and gross margin, plus a technically weak setup with the stock below key moving averages and negative MACD. Valuation is also constrained by a negative P/E (loss-making), offering limited earnings-based support.
Positive Factors
Revenue and gross-margin expansion
Strong revenue growth alongside improving gross margin indicates increasing commercial traction and better unit economics. If sustained, this combination can support greater operating leverage, strengthen reinvestment capacity, and improve the company’s ability to scale its surgical robotics platform.
Negative Factors
Persistent operating and net losses
Despite higher revenue and gross margin, the company has not yet converted growth into sustainable profitability. Continued operating and net losses could constrain internal investment, require additional financing, and make future performance more dependent on achieving meaningful scale and operating leverage.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and gross-margin expansion
Strong revenue growth alongside improving gross margin indicates increasing commercial traction and better unit economics. If sustained, this combination can support greater operating leverage, strengthen reinvestment capacity, and improve the company’s ability to scale its surgical robotics platform.
Read all positive factors
SS Innovations International (SSII) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$501.20M
Dividend YieldN/A
Average Volume (3M)65.06K
Price to Earnings (P/E)―
Beta (1Y)0.66
Revenue Growth89.98%
EPS Growth-0.32%
CountryUS
Employees483
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.07
Shares Outstanding200,478,420
10 Day Avg. Volume51,523
30 Day Avg. Volume65,059
Financial Highlights & Ratios
PEG Ratio2.12
Price to Book (P/B)28.24
Price to Sales (P/S)25.40
P/FCF Ratio-48.61
Enterprise Value/Market Cap1.65
Enterprise Value/Revenue15.77
Enterprise Value/Gross Profit33.54
Enterprise Value/Ebitda-133.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)$59.60M
SS Innovations International Business Overview & Revenue Model
Company Description
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite ...
SS Innovations International Financial Statement Overview
Summary
Income Statement
41
Neutral
Balance Sheet
63
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.39M | 42.48M | 20.65M | 5.88M | 1.46M | 0.00 |
| Gross Profit | 24.63M | 19.54M | 8.45M | 713.45K | 489.59K | -18.79K |
| EBITDA | -6.21M | -5.98M | -17.74M | -20.27M | -5.34M | -1.47M |
| Net Income | -12.43M | -12.13M | -19.15M | -20.94M | -5.60M | -1.48M |
Balance Sheet | ||||||
| Total Assets | 96.98M | 74.23M | 42.39M | 25.48M | 6.98M | 428.61K |
| Cash, Cash Equivalents and Short-Term Investments | 13.65M | 3.21M | 466.50K | 7.03M | 217.18K | 405.77K |
| Total Debt | 3.24M | 14.36M | 18.20M | 8.22M | 8.27M | 145.00K |
| Total Liabilities | 43.58M | 36.01M | 28.93M | 11.18M | 9.66M | 287.28K |
| Stockholders Equity | 53.40M | 38.22M | 13.46M | 14.30M | -2.68M | 141.33K |
Cash Flow | ||||||
| Free Cash Flow | -18.22M | -22.20M | -10.16M | -15.81M | -1.44M | -363.03K |
| Operating Cash Flow | -15.53M | -18.54M | -9.50M | -15.36M | -5.99M | -363.03K |
| Investing Cash Flow | -2.68M | -3.66M | -661.48K | -453.33K | 240.82K | 38.15K |
| Financing Cash Flow | 26.10M | 26.17M | 9.43M | 22.80M | 5.90M | 569.95K |
SS Innovations International Technical Analysis
Negative
3.83
Price Trends
3.03
Negative
3.35
Negative
3.93
Negative
Market Momentum
-0.19
Negative
41.09
Neutral
33.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SSII, the sentiment is Negative. The current price of 3.83 is above the 20-day moving average (MA) of 2.59, above the 50-day MA of 3.03, and below the 200-day MA of 3.93, indicating a bearish trend. The MACD of -0.19 indicates Negative momentum. The RSI at 41.09 is Neutral, neither overbought nor oversold. The STOCH value of 33.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SSII.
SS Innovations International Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $1.21B | 17.95 | 28.39% | ― | 3.14% | ― | |
61 Neutral | $621.94M | -16.66 | -9.91% | ― | 14.49% | 6.68% | |
59 Neutral | $960.91M | -63.10 | -8.23% | ― | 15.30% | 40.66% | |
55 Neutral | $395.51M | -6.32 | -14.05% | ― | 2.99% | 51.77% | |
52 Neutral | $295.91M | -4.89 | -74.06% | ― | -3.95% | -17.90% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $501.20M | -38.34 | -26.77% | ― | 89.98% | -0.32% |
* Healthcare Sector Average
SSII
SS Innovations International
2.50
-6.02
-70.66%
OFIX
Orthofix Medical
9.71
-6.31
-39.39%
KIDS
OrthoPediatrics
23.82
6.91
40.86%
SIBN
SI-Bone
21.44
5.65
35.78%
BVS
Bioventus
14.42
7.48
107.78%
TMCI
Treace Medical Concepts
4.55
-2.29
-33.48%
SS Innovations International Corporate Events
Business Operations and StrategyProduct-Related Announcements
SS Innovations Advances Global Telesurgery with Robotic Platform
Positive
Oct 26, 2026
SS Innovations International, Inc., a U.S. surgical robotics developer headquartered in India, is expanding its global footprint with the SSi Mantra system, the SSi MantrAsana tele-surgeon console and SSi Mudra instruments, designed to deliver cos...
Business Operations and StrategyProduct-Related AnnouncementsRegulatory Filings and Compliance
SS Innovations advances FDA review for SSi Mantra robot
Positive
Oct 13, 2026
On October 13, 2026, SS Innovations International, Inc. reported that it had submitted a response on October 5, 2026, to a U.S. Food and Drug Administration request for additional information tied to its 510(k) application for the SSi Mantra surgi...
Private Placements and Financing
SS Innovations International Secures Major Convertible Note Financing
Positive
Oct 13, 2026
On October 9, 2026, SS Innovations International entered into and closed a Securities Purchase Agreement with an institutional investor, issuing a secured convertible promissory note with an original principal amount of $21.03 million for $20 mill...
Business Operations and StrategyFinancial Disclosures
SS Innovations Unveils Updated Global Growth Presentation
Positive
Oct 5, 2026
SS Innovations International, Inc., a Nasdaq-listed surgical robotics developer, is positioning its SSi Mantra 3 system as an affordable alternative in a rapidly expanding global market for robotic surgery. The company leverages AI- and XR-driven ...
Business Operations and Strategy
SS Innovations Marks Rapid Global Robotic Surgery Expansion
Positive
Sep 10, 2026
On September 10, 2026, SS Innovations International reported a series of operational milestones highlighting rapid global expansion and growing adoption of its SSi Mantra surgical robotic system. By early September, the installed base had reached ...
Executive/Board Changes
SS Innovations Announces Chief Financial Officer Leadership Change
Neutral
Aug 26, 2026
SS Innovations International, a company in the medical technology sector, did not provide additional details about its industry focus, products, or markets in the announcement, leaving its broader operating profile unspecified in this release.Effe...
Business Operations and StrategyFinancial Disclosures
SS Innovations Reports Record Revenue Amid Expanding Robotics Footprint
Positive
Aug 13, 2026
On August 13, 2026, SS Innovations reported unaudited results for the quarter and first half ended June 30, 2026, posting record second-quarter revenue of $13.9 million, up 39.4% year on year, and first-half revenue of $25.0 million, up 65.6%, dri...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.